Effect of age and gender on the relationship between alcohol consumption and serum GGT: Time to recalibrate goals for normal ranges

Alcohol and Alcoholism

Volumn 47, Issue 5, 2012, Pages 558-562

  Tynjälä, Joanna ^a   Kangastupa, Päivikki ^a   Laatikainen, Tiina ^b,c   Aalto, Mauri ^b,d   Niemelä, Onni ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d SEINÄJOKI CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; HEALTH SURVEY; HUMAN; LIVER DYSFUNCTION; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; SEX FACTORS;

EID: 84865316130     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/ags072     Document Type: Article

References (34)

1. Alatalo PI, Koivisto HM, Hietala JP et al. (2008) Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am J Clin Nutr 88:1097-103.
2. Conigrave KM, Degenhardt LJ, Whitfield JB et al. (2002) CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 26:332-9.
3. Corrao G, Bagnardi V, Zambon A et al. (2004) A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 38:613-9.
4. Daeppen JB, Anex F, Leutwyler J et al. (2004) Role of high normal gamma-glutamyltransferase level in identifying heavy alcohol use in young men. Alcohol 32:157-61.
5. Di Castelnuovo A, Costanzo S, Bagnardi V et al. (2006) Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med 166:2437-45.
6. Emdin M, Pompella A, Paolicchi A. (2005) Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 112:2078-80.
7. Gunzerath L, Faden V, Zakhari S et al. (2004) National Institute on Alcohol Abuse and Alcoholism report on moderate drinking. Alcohol Clin Exp Res 28:829-47.
8. Ikeda Y, Taniguchi N. (2005) Gene expression of gammaglutamyltranspeptidase. Meth Enzymol 401:408-25.
9. Kazemi-Shirazi L, Endler G, Winkler S et al. (2007) Gamma glutamyltransferase and long-term survival: is it just the liver? Clin Chem 53:940-6.
10. Kornhuber HH, Kornhuber J, Wanner W et al. (1989) Alcohol, smoking and body build: obesity as a result of the toxic effect of social alcohol consumption. Clin Physiol Biochem 7:203-16.
11. Lee DH, Jacobs DR, Jr, Gross M et al. (2003) Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 49:1358-66.
12. Lee DH, Blomhoff R, Jacobs DR, Jr. (2004) Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res 38:535-9.
13. Lee DH, Ha MH, Kam S et al. (2006a) A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among South Korean men. Am J Epidemiol 163:57-65.
14. Lee DH, Silventoinen K, Hu G et al. (2006b) Serum gammaglutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J 27:2170-6.
15. Lee DH, Buijsse B, Steffen L et al. (2009) Association between serum gamma-glutamyltransferase and cardiovascular mortality varies by age: the Minnesota Heart Survey. Eur J Cardiovasc Prev Rehabil 16:16-20.
16. Leino A, Impivaara O, Irjala K et al. (1995) Health-based reference intervals for ALAT, ASAT and GT in serum, measured according to the recommendations of the European Committee for Clinical Laboratory Standards (ECCLS). Scand J Clin Lab Invest 55:243-50.
17. Mason JE, Starke RD, Van Kirk JE. (2010) Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol 13:36-41.
18. Mistry D, Stockley RA. (2010) Gamma-glutamyl transferase: the silent partner? COPD 7:285-90.
19. Mukamal KJ, Rimm EB. (2008) Alcohol consumption: risks and benefits. Curr Atheroscler Rep 10:536-43.
20. Niemelä O. (2007) Biomarkers in alcoholism. Clin Chim Acta 377:39-49.
21. Nyström M, Peräsalo J, Pikkarainen J et al. (1993) Conventional laboratory tests as indicators of heavy drinking in young university students. Scand J Prim Health Care 11:44-9.
22. Puukka K, Hietala J, Koivisto H et al. (2006) Age-related changes on serum ggt activity and the assessment of ethanol intake. Alcohol Alcohol 41:522-7.
23. Room R, Babor T, Rehm J. (2005) Alcohol and public health. Lancet 365:519-30.
24. Royal College of Psychiatrists. Our invisible addicts. College Report CR165. London: Royal College of Psychiatrists, 2011.
25. Ruttmann E, Brant LJ, Concin H et al. (2005) Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 112:2130-7.
26. Ryu S, Chang Y, Woo HY et al. (2010) Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men. Metabolism 59:683-9.
27. Sillanaukee P, Aalto M, Seppä K. (1998) Carbohydrate-deficient transferrin and conventional alcohol markers as indicators for brief intervention among heavy drinkers in primary health care. Alcohol Clin Exp Res 22:892-6.
28. Sillanaukee P, Massot N, Jousilahti P et al. (2000) Dose response of laboratory markers to alcohol consumption in a general population. Am J Epidemiol 152:747-51.
29. Sohal RS, Weindruch R. (1996) Oxidative stress, caloric restriction, and aging. Science 273:59-63.
30. Strasak AM, Rapp K, Brant LJ et al. (2008) Association of gammaglutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res 68:3970-7.
31. oC: part of the Nordic Reference Interval Project. Scand J Clin Lab Invest 64:371-84.
32. Targher G. (2010) Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer-a narrative review. Clin Chem Lab Med 48: 147-57.
33. The World Health Organization (1988) The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. J Clin Epidemiol 41:105-14.
34. Zhang H, Forman HJ. (2009) Redox regulation of gamma-glutamyl transpeptidase. Am J Respir Cell Mol Biol 41:509-15.